- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04415034
Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis
Pediculosis capitis is a parasitic infestation that can cause scalp pruritus and quality of life disturbances. There are two objective measurement for pruritus, visual analog scale (VAS) and 5-D itch scale, which can assess the severity of the scalp pruritus and the latter can also asses the quality of life affected by pruritus. Even though VAS can not be used to evaluate the impact of pruritus on quality of life, it is very easy to use while 5-D itch scale is complex and not child-friendly.
The aim of this study is to determine the relationship between two different pruritus scales and to establish validity of pruritus VAS scale in evaluating quality of life in children with pediculosis capitis. We compare two pruritus scale on students with pediculosis of two boarding school in Bogor, West Java, Indonesia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study used cross sectional design study.
Subjects with eligible criteria were included and informed consent from the parents or legal guardian were obtained.
The diagnosis of pediculosis capitis was made based on the findings of eggs, larva, or an adult parasite on the scalp or in the hair of the students. All subjects were asked for both VAS and 5-D itch scale.The VAS is categorized into five groups based on the point, as follows: 0 for no pruritus, <3 for mild pruritus, ≥ 3 - <7 for moderate pruritus, ≥ 7 - <9 for severe pruritus, and ≥ 9 for very severe pruritus. The 5-D itch scale consists of five parameters: duration, degree, direction, disability (sleep, leisure/social activities, housework/errands, work/school), and distribution of the pruritus with points ranging from one to five.
Data were recorded for statistical analysis, a chi-square test was used to determine the relationship between two categorical variables. The correlation coefficient between the VAS and 5-D itch scale was calculated using Spearman's rank correlation
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Jawa Barat
-
Bogor, Jawa Barat, Indonesia
- Pesantren Al Hidayah Cibinong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Students studying in Junior high school at Boarding School in Bogor with medium length hair who were clinically diagnosed with pediculosis capitis
- Willingness to participate as a research subject (to be interviewed and undergo physical examination), and after being explained the details of the study, granted the headmaster permission to sign consent in their name (informed assent)
Exclusion Criteria:
- Chemical treatment of PC within 10 days before the trial
- History of permethrin hypersensitivity
- Unwillingness to participate as a research subject
- Mild-to-severe secondary infection
- Long or short hair
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pediculosis capitis
Subjects with pediculosis capitis based on the findings of eggs, larva, or an adult parasite on the scalp or in the hair
|
All subjects were evaluated for presence of pruritus using VAS and 5-D itch scale
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pruritus severity (1)
Time Frame: Baseline, during examination
|
Pruritus severity evaluated by visual analog scale (VAS)
|
Baseline, during examination
|
Pruritus severity (2)
Time Frame: Baseline, during examination
|
Pruritus severity evaluated by 5-D itch scale
|
Baseline, during examination
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sandra Widaty, MD, PhD, Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0920/UN2.F1/ETIK/2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pruritus
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Toray Industries, IncCompletedUremic PruritusBulgaria, Germany
-
Cara Therapeutics, Inc.CompletedPruritus | Uremic PruritusUnited States
-
Thammasat University HospitalCompletedUremic PruritusThailand
-
Conmed Pharmaceutical & Bio-Medical CorporationChang Gung Memorial Hospital; Kaohsiung Medical University; Tri-Service General... and other collaboratorsCompleted
-
Haisco Pharmaceutical Group Co., Ltd.Completed
-
Kissei Pharmaceutical Co., Ltd.Maruishi PharmaceuticalCompleted
-
Chang Gung Memorial HospitalUnknown
-
Lumosa Therapeutics Co., Ltd.Unknown
-
RDD Pharma LtdWithdrawn
Clinical Trials on VAS and 5-D itch pruritus assessment
-
Fondazione Policlinico Universitario Agostino Gemelli...Prof. Massimo Cordaro; Dr. Romeo Patini; Dr. Oliva Giorgio; Dr. Candida Ettore; Dr... and other collaboratorsCompletedCicatrix | Cleft Lip and Palate | Randomized Controlled Trial | Growth and DevelopmentItaly
-
University Hospital, ToulouseUnknownDomestic ViolenceFrance
-
SMG-SNU Boramae Medical CenterUnknownPostoperative Cognitive Dysfunction
-
Balgrist University HospitalUniversity of ZurichCompletedPain, Back | Arthropathy of Lumbar FacetSwitzerland
-
Methodist Health SystemActive, not recruitingFractures, Bone | Fracture | Vitamin D | Fracture NonunionUnited States
-
National Opinion Research CenterCenters for Disease Control and Prevention; Emory HealthcareCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
Serum Institute of India Pvt. Ltd.PATHCompletedMeningococcal MeningitisGambia, Mali
-
OctapharmaCompletedPrimary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIGCanada, Austria, France, Spain, United Kingdom
-
Assiut UniversityNot yet recruitingColorectal Neoplasms